TGaS Advisors, a division of Trinity
Chris Welsh is currently serving as the Vice President of Medical Affairs at TGaS Advisors since February 2019. Prior to that, Chris held the position of Executive Director and Head of Medical Affairs at Lipocine Inc. from September 2016 to October 2018. With a background in pharmaceuticals, Chris has also worked at various other companies in roles such as Director of Medical Affairs at Orexo US, Inc. and in various positions at Shire Pharmaceuticals. Chris holds an MBA from Villanova University and a PharmD from the University of the Sciences in Philadelphia.
TGaS Advisors, a division of Trinity
TGaS Advisors, a division of Trinity Life Sciences, is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of top 50, emerging and precommercial life sciences companies, TGaS provides robust comparative intelligence and collaborative network membership services. The team includes more than 60 experienced professionals, most with senior-level experience in the life sciences and related industries.